A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study

This publication has 19 references indexed in Scilit:

• GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy^*
  HIV Medicine, 2004
• Treatment for Adult HIV Infection
  JAMA, 2004
• Impact of different HIV resistance interpretation by distinct systems on clinical utility of resistance testing
  Current Opinion in Infectious Diseases, 2003
• Comparison between Rules‐Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients
  The Journal of Infectious Diseases, 2003
• Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
  AIDS, 2003
• High Variability of Plasma Drug Concentrations in Dual Protease Inhibitor Regimens
  Antimicrobial Agents and Chemotherapy, 2003
• Methods for Integration of Pharmacokinetic and Phenotypic Information in the Treatment of Infection with Human Immunodeficiency Virus
  Clinical Infectious Diseases, 2003
• PharmAdapt
  AIDS, 2002
• High Indinavir Cmin Is Associated With Higher Toxicity in Patients on Indinavir-Ritonavir 800/100 mg Twice-Daily Regimen
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir
  Antimicrobial Agents and Chemotherapy, 2002